NCT04314128

Brief Summary

Idiopathic Intracranial Hypertension (IIH) is a rare disease, primarily affecting overweight females of child-bearing age. Patients suffer from increased intracranial pressure (ICP), typically resulting in headaches, visual disturbances and bilateral papilledema, pulsatile tinnitus and cognitive deficits. The disease is difficult to diagnose, treat and monitor. The only current method of measuring the ICP in day-to-day clinical practice is by lumbar puncture. This procedure is invasive, and often painful for the patient. There is an unmet need of methods that can reliable measure or estimate ICP in a non-invasive manner. Ultrasound is one such potential method, and the aim of this study is to investigate the use of ocular ultrasound and transcranial doppler to measure or estimate ICP.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
78

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2020

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

March 12, 2020

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 19, 2020

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2023

Completed
Last Updated

March 7, 2023

Status Verified

March 1, 2023

Enrollment Period

3.1 years

First QC Date

March 12, 2020

Last Update Submit

March 6, 2023

Conditions

Outcome Measures

Primary Outcomes (3)

  • Correlation between opening pressure and ONSD

    Optic nerve sheath diameter (ONSD) potential correlation with opening pressure.

    1 year

  • Correlaton between opening pressure and ONSD/ETD ratio

    ONSD/ETD (external transverse diameter) ratio and potential correlation with opening pressure.

    1 year

  • Comparison of ONSD in IIH and healthy controls

    Comparison of ONSD in patients with elevated ICP (IIH) and healthy controls, age- sex and BMI matched.

    1 year

Secondary Outcomes (10)

  • Optic disc elevation

    1 year

  • ONSD diameter on MR c in patients with IIH

    1 year

  • Changes in the optic nerve (ONSD)

    1 month

  • Changes in the optic nerve (ONSD)

    6 months

  • Changes in the optic nerve (ODE)

    1 month

  • +5 more secondary outcomes

Study Arms (1)

Patients suspected of IIH at baseline

OTHER

Intervention: TOS and TCD measurements at baseline, and at routine follow-ups. Healthy controls will be recruited to match the patients.

Diagnostic Test: TOS and TCD

Interventions

TOS and TCDDIAGNOSTIC_TEST

TOS: Transorbital sonography TCD: Transcranial Doppler

Patients suspected of IIH at baseline

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18-65
  • Patients in whom the IIH diagnosis is suspected/or confirmed
  • The diagnosis of migraine with or without aura or tension-type headache is allowed as a comorbid headache type.
  • Participants must read and understand the Danish language, or have an official interpreter present to be able to understand the work-up and sign the participation consent for the study

You may not qualify if:

  • Pregnant or breastfeeding females
  • Patients who do not need a diagnostic lumbar puncture at the time of evaluation
  • Any other primary or secondary headache diagnosis than migraine with or without aura or tension type headache as a comorbid disorder
  • Patients in whom the examination cannot be performed due to anatomical reasons such as severe head dysmorphia or severe ophthalmological diseases
  • Participants with secondary causes of raised intracranial pressure, or patients that have been treated for such (e.g. brain tumor, hydrocephalus, stroke or severe head injury)
  • Participants with known atherosclerotic disease or known heart disease
  • CONTROL GROUP (ARM 2):
  • Age 18-65
  • Healthy persons who do not suffer from any form of primary headache except infrequent tension-type headache
  • Participants must read and understand the Danish language or have an official interpreter present to be able to sign the participation consent for the study.
  • Pregnant or breastfeeding females
  • Participants in whom the examination cannot be performed due to anatomical reasons such as severe head dysmorphia or severe ophthalmological diseases

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Danish Headache Center

Glostrup Municipality, Capital Region, 2600, Denmark

Location

MeSH Terms

Conditions

Pseudotumor Cerebri

Interventions

Ultrasonography, Doppler, Transcranial

Condition Hierarchy (Ancestors)

Intracranial HypertensionBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Intervention Hierarchy (Ancestors)

EchoencephalographyNeuroradiographyNeuroimagingDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisRadiographyUltrasonographyUltrasonography, DopplerDiagnostic Techniques, NeurologicalInvestigative Techniques

Study Officials

  • Rigmor Jensen, Dr.med.

    Danish Headache Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Model Details: Single group, prospective cohort study with healthy controls.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical Doctor

Study Record Dates

First Submitted

March 12, 2020

First Posted

March 19, 2020

Study Start

January 1, 2020

Primary Completion

February 1, 2023

Study Completion

February 1, 2023

Last Updated

March 7, 2023

Record last verified: 2023-03

Data Sharing

IPD Sharing
Will not share

Locations